ZEISS Ventures
ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, headquartered in Oberkochen, Germany. It is a strategic deep-tech investor targeting pre-Series A and Series A start-ups in Industrial Tech, MedTech and Life Sciences, writing initial tickets of EUR 0.5-5 million from an evergreen balance-sheet-funded programme. The team focuses on technology-driven ventures combining software and hardware with scalable global B2B business models, primarily across Europe and North America.
ZEISS Ventures is an Oberkochen venture capital firm with €140M AUM, 13 active companies and 3 exits.
- ·3 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 3 realized deals: 7 years.
- ·Top sector focus: MedTech (44% of portfolio).
Sector breakdown
16 companiesGeography breakdown
6 geographiesKey facts
Recent exits
ZEISS Ventures sold Scantinel Photonics to MicroVision in 2025 after 4 years.
ZEISS Ventures sold Bridger Photonics to Beaverhead Partners LLC in 2022 after 4 years.
ZEISS Ventures sold Nanoscribe to CELLINK (BICO Group) in 2021 after 13 years.
Coverage notes
1 fund tracked, 16 portfolio companies (13 active · 3 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund ZEISS Ventures has raised, with its portfolio companies. Hand-checked from public filings.
ZEISS Ventures CVCActiveEvergreen2019€140M13 assets3 exitsEvergreen2019 · 7yr€140M133
Unrealized
13 held| Company | Entry |
|---|---|
| arcoris bio Biotech · Switzerland | 2025 |
| Creal Deep Tech · Switzerland | 2024 |
| Custom Surgical MedTech · Germany | 2026 |
| Hypervision Surgical MedTech · UK | 2023 |
| InSphero Biotech · Switzerland | 2023 |
| Lidrotec Deep Tech · Germany | 2025 |
| Maculaser MedTech · Finland | 2026 |
| Mindpeak HealthTech · Germany | 2024 |
| Morrow Consumer · Norway | 2022 |
| Odne MedTech · Switzerland | 2025 |
| Surgify Medical MedTech · Finland | 2025 |
| Vibrosonic MedTech · Germany | 2023 |
| ZOMP MedTech · UK | 2023 |
Realized
3 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Bridger Photonics Deep Tech · US | 2018 | 2022 | Trade Sale | Beaverhead Partners LLC | – |
| Nanoscribe Deep Tech · Germany | 2008 | 2021 | Trade Sale | CELLINK (BICO Group) | – |
| Scantinel Photonics Deep Tech · Germany | 2021 | 2025 | Trade Sale | MicroVision | – |
Frequently asked questions
- What investment strategy does ZEISS Ventures focus on?
- ZEISS Ventures focuses on VC, Growth strategies in the private equity space.
- How many portfolio companies does ZEISS Ventures have?
- ZEISS Ventures has 13 active portfolio companies and 3 completed exits and 1 fund tracked on GP Intel.
- Where is ZEISS Ventures headquartered?
- ZEISS Ventures is headquartered in Oberkochen, Germany.
- What is ZEISS Ventures's assets under management?
- ZEISS Ventures manages approximately €140M in assets under management.
- When was ZEISS Ventures founded?
- ZEISS Ventures was founded in 2019.
- What sectors does ZEISS Ventures invest in?
- ZEISS Ventures invests across Healthcare, Industrials, TMT.
- What are ZEISS Ventures's recent exits?
- Recent realized exits by ZEISS Ventures include: Scantinel Photonics (2025) to MicroVision; Bridger Photonics (2022) to Beaverhead Partners LLC; Nanoscribe (2021) to CELLINK (BICO Group).
Similar firms
Other private equity firms tracked on GP Intel.